According to BioCryst Pharmaceuticals, the maker of Orladeyo, the medicine will be provided exclusively by specialty pharmacy Optime Care
Recently, CareMetx started a new division, OutcomeRx, to focus on holistic solutions for biotech companies to address the patient, manufacturer, and payer challenges in the evolving Cell and Gene Therapy (CGT) market
Conduent has resources and expertise to process millions of documents or transactions across a range of industries and works with patient enrollment, benefits verification and prior authorization paperwork
EVERSANA serves more than 500 organizations, including innovative start-ups and established pharmaceutical companies
RareMed Solutions is the nation’s only (pure) rare and devastating disorder patient service provider (PSP)
EVERSANA™ has aggressively invested in technology, data and people to activate data-driven engagement to advance access and adherence at each stage of the product life cycle
RemedyOne is helping clients rethink, refine and re-value processes, relationships and how they do business. RemedyOne, with a focus on employers, works with clients so they can profit from better outcomes and new ways of solving old problems, including: Rebate and Formulary Management Outcome-Focused Consulting Healthcare Solutions Drug reimbursement Network solutions Outcome improvement RemedyOne’s 360° […]
UroGen has been preparing for the commercialization of Jelmyto by increasing customer awareness and discussing the high unmet need in low-grade UTUC